Skip to main content

Lupin-Natco get USFDA nod to market generic hypertension drug

Lupin-Natco get USFDA nod to market generic hypertension drug The approval by the United States Food and Drug Administration (USFDA) is for marketing Bosentan tablets in the strengths of 62.5 mg and 125 mg, Lupin said in a statement.

from Moneycontrol Business News http://bit.ly/2ZDtkjQ

Comments

Popular posts from this blog

German cabinet to hold secret session on Huawei#39;s role in 5G network: Report

Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology for spying, which the company denies. from Moneycontrol Business News http://bit.ly/2TyXzFb

Infosys partners Avaloq to strengthen wealth management capabilities via digital platforms

Infosys will be a strategic implementation partner for Avaloq#39;s wealth management suite of solutions to help clients modernize and transform their legacy systems into cutting-edge digital advisory platforms, a statement said. from Moneycontrol Business News https://ift.tt/2THaSpn